Skip to main content
OpenTrials

Clinical trial condition

Digestive System Neoplasms

Explore clinical trials studying Digestive System Neoplasms. Study availability and eligibility vary by location and protocol.

14,292 public trials 3,244 recruiting studies
Refine in advanced search Browse all conditions

Digestive System Neoplasms trial results

Completed

Panitumumab, Docetaxel, Cisplatin, Radiation Therapy, and Surgery in Treating Patients With Newly Diagnosed, Locally Advanced Esophageal Cancer or Cancer of the Gastroesophageal Junction

NCT00757172

Conditions
Adenocarcinoma Of Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Digestive System Diseases, +9 more
Locations
  • Curtis and Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center Savannah, Georgia, United States
  • Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States
  • University of Chicago Cancer Research Center Chicago, Illinois, United States
  • Evanston Hospital Evanston, Illinois, United States
View all 21 locations
View Trial Details
Completed

A Study Evaluating STA-9090 in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor (GIST)

NCT01039519

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +7 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Oregon Health and Science University-Knight Cancer Institute Portland, Oregon, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
View Trial Details
Completed

A Phase II, Trial of Ixabepilone Plus Cetuximab as First Line Therapy for Metastatic Pancreatic Cancer

NCT00383149

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Georgetn Univ Lombardi Can Ctr Washington D.C., District of Columbia, United States
  • Mayo Clinic Jacksonville Jacksonville, Florida, United States
  • University Of Miami Miami, Florida, United States
  • University Of Michigan Ann Arbor, Michigan, United States
View Trial Details
Completed

A Phase I / II Trial of Nintedanib in Asian Hepatocellular Carcinoma Patients

NCT00987935

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
Locations
  • 1199.39.82001 Boehringer Ingelheim Investigational Site Seoul, South Korea
  • 1199.39.82002 Boehringer Ingelheim Investigational Site Seoul, South Korea
  • 1199.39.82003 Boehringer Ingelheim Investigational Site Seoul, South Korea
  • 1199.39.82004 Boehringer Ingelheim Investigational Site Seoul, South Korea
View all 16 locations
View Trial Details
Completed

Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy

NCT01658943

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +9 more
Locations
  • The University of Arizona Cancer Center-Orange Grove Campus Tucson, Arizona, United States
  • The University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Kaiser Permanente-Anaheim Anaheim, California, United States
View all 534 locations
View Trial Details

Related conditions